Insights

FDA breakthrough Innoblative holds FDA Breakthrough Device Designation for the SIRA RFA Electrosurgical Device, signaling a priority for advanced surgical solutions and potential preference from hospitals and surgeons seeking cutting-edge breast and soft tissue care.

Opportunity in BCS The SIRA device is investigational for breast-conserving surgery and not yet saleable in the US, presenting a clear near-term sales opportunity with early adopters in academic centers and key breast surgeons as the device progresses toward market readiness.

Growth potential With revenue in the low-to-mid single digits and a recent funding round, Innoblative is positioned to scale; potential opportunities include strategic partnerships or pilot programs with large medical device distributors to accelerate market penetration.

Clinical focus Aimed at improving coagulation and ablation of soft tissue, the company targets breast cancer and other soft tissue diseases, suggesting cross-sell potential to hospitals and surgical centers performing breast-conserving therapies and related procedures.

Industry fit Comparable medtech peers and large players in breast and surgical devices indicate a receptive market where partnerships with major manufacturers or distributors could amplify adoption, channel reach, and credentialing among surgeons and institutions.

Similar companies to Innoblative

Innoblative Tech Stack

Innoblative uses 8 technology products and services including iCIMS, RSS, WordPress, and more. Explore Innoblative's tech stack below.

Innoblative's Email Address Formats

Innoblative uses at least 3 email formats:
Innoblative Email FormatsExamplePercentage
First@innoblative.comJohn@innoblative.com
65%
FLast@innoblative.comJDoe@innoblative.com
23%
First.Last@innoblative.comJohn.Doe@innoblative.com
12%

Frequently Asked Questions

What is Innoblative's phone number?

Minus sign iconPlus sign icon
You can contact Innoblative's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Innoblative's official website and social media links?

Minus sign iconPlus sign icon
Innoblative's official website is innoblative.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Innoblative generate?

Minus sign iconPlus sign icon
As of November 2026, Innoblative's annual revenue is estimated to be $1M - $10M.

What is Innoblative's NAICS code?

Minus sign iconPlus sign icon
Innoblative's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Innoblative have currently?

Minus sign iconPlus sign icon
As of November 2026, Innoblative has approximately 12 employees across 2 continents, including North America and Europe. Key team members include Chief Executive Officer: K. L. and Medical Consultant: N. C. Explore Innoblative's employee directory with LeadIQ.

What industry does Innoblative belong to?

Minus sign iconPlus sign icon
Innoblative operates in the Medical Equipment Manufacturing industry.

What technology does Innoblative use?

Minus sign iconPlus sign icon
Innoblative's tech stack includes iCIMS, RSS, WordPress, Microsoft 365, Google Cloud, WP Engine, Piwik PRO Core and RankMath SEO.

What is Innoblative's email format?

Minus sign iconPlus sign icon
Innoblative's email format typically follows the pattern of First@innoblative.com. Find more Innoblative email formats with LeadIQ.

How much funding has Innoblative raised to date?

Minus sign iconPlus sign icon
As of November 2026, Innoblative has raised $9.1M in funding. The last funding round occurred on Oct 01, 2021.

When was Innoblative founded?

Minus sign iconPlus sign icon
Innoblative was founded in 2013.
Innoblative logo

Innoblative

Medical Equipment ManufacturingIllinois, United States11-50 Employees

Innoblative Designs, Inc. is a private medical device company focused on addressing clinical unmet needs for patients with breast cancer and other soft tissue diseases. It develops energy-based surgical solutions intended to improve how surgeons coagulate and ablate soft tissue. The company's SIRA RFA Electrosurgical Device has been designated a Breakthrough Device by the FDA. The device is investigational for use in breast-conserving surgery and is not yet available for sale in the United States, though it is cleared for intraoperative coagulation and ablation of soft tissue.

Based in Chicago, Illinois, Innoblative operates in the medical equipment manufacturing industry with a small to mid-sized team. Its work centers on surgical technologies for breast cancer and other soft tissue conditions.

Section iconCompany Overview

Phone number
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2013
Employees
11-50

Section iconFunding & Financials

  • $9.1M

    Innoblative has raised a total of $9.1M of funding over 7 rounds. Their latest funding round was raised on Oct 01, 2021 as a Seed.

  • $1M - $10M

    Innoblative's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.